Biotechs have underperformed the broader market this year, and these stock are at crossroads as they await the new ...

Vertex Pharmaceuticals stock is trading red on the day by 0.24%, trading at $476.55 a share. Second, Regeneron Pharmaceuticals Inc. (REGN) is a biotechnology company that discovers, develops ...

Allison DeAngelis, who covers biotech startups and venture capital, is also the author of STAT’s annual report “Ranking Biotech’s Top Venture Capital Firms.” Biotech investors have been ...

The significance of two healthy ferrets born to Antonia, a cloned female, "cannot be overstated" in the world of wildlife conservation, said Ben Novak, lead scientists for Revive & Restore, a ...

The capital markets watchdog SEBI has received preliminary documents from Paramesu Biotech Ltd. seeking to raise Rs 600 crore ...

The Paramesu Biotech IPO consists of a fresh issue of shares worth up to Rs 520 crore and an offer for sale of shares worth ...

Rallybio is headed into a mid-stage trial with enough cash through 2026, but the cyclical market has made the journey ...

A K Sood, principal scientific advisor to GoI told TOI: "I don't see any major red flag or reason to expect drastic changes .

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

Maize-based speciality products maker Paramesu Biotech has filed preliminary papers with the capital ... If it completes the ...

Paramesu Biotech, a leading maize-based products manufacturer, files IPO papers with Sebi to raise Rs 600 crore. The IPO ...